v3.25.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
ASSETS    
Cash $ 1,028,870 $ 3,378,152
Digital assets - current (Note 2) 8,231,963 9,021,927
Finance receivables 21,910 21,051
Marketable securities (Note 5) 18,340 27,050
Receivable from sale of Symbiont assets (Note 5)   200,000
Prepaid expenses and other assets 899,036 827,237
Income tax receivable 31,187 31,187
Current assets 10,231,306 13,506,604
Fixed assets, net (Note 3) 16,377,635 18,376,948
Intangible assets, net (Note 3) 5,423,985 5,478,958
Deposits on mining equipment (Note 4) 947,348 467,172
Long-term investments - equity securities (Note 5) 7,251 4,255
Investment in Seastar Medical Holding Corporation (Note 5) $ 171,810 $ 200,790
Investment, Issuer Affiliation [Extensible Enumeration] us-gaap:InvestmentAffiliatedIssuerMember us-gaap:InvestmentAffiliatedIssuerMember
Digital assets - long-term (Note 2) $ 5,000,000 $ 5,000,000
Right of use assets (Note 7) 888,049 938,641
Other assets 73,857 73,857
Long-term assets 28,889,935 30,540,621
Total assets 39,121,241 44,047,225
Liabilities and stockholders' equity    
Accounts payable and accrued expenses 1,359,891 989,563
Note payable - short-term (Note 6) 361,547 386,312
Due to related parties (Note 9) $ 37,312 $ 15,944
Other Liability, Current, Related Party [Extensible Enumeration] Related Party [Member] Related Party [Member]
Current portion of lease liability (Note 7) $ 188,763 $ 170,967
Total current liabilities 1,947,513 1,562,786
Note payable - long-term (Note 6) 6,386,609 6,365,345
Lease liability - net of current portion (Note 7) 748,054 776,535
Long-term liabilities 7,134,663 7,141,880
Total liabilities 9,082,176 8,704,666
Stockholders' equity (Note 8)    
Preferred stock, par value $.001; 150,000,000 shares authorized; no shares issued and outstanding as of March 31, 2025 and December 31, 2024
Common stock, par value $.001; 350,000,000 shares authorized; 5,133,412 shares issued and outstanding as of March 31, 2025 and December 31, 2024 4,602 4,602
Additional paid-in capital 102,789,990 102,685,470
Accumulated deficit (71,061,405) (65,662,731)
Total LM Funding America stockholders' equity 31,733,187 37,027,341
Non-controlling interest (1,694,122) (1,684,782)
Total stockholders’ equity 30,039,065 35,342,559
Total liabilities and stockholders’ equity $ 39,121,241 $ 44,047,225

Source

HTML PDF
ZIP